FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Agent, Injectable, Embolic

PMA: P030004 · Supplement: S031 · Decision Apr 16, 2024
Classifications
1
FEI Numbers
4
Registration Numbers
4

Basic Information

Device Name
Agent, Injectable, Embolic
Trade Name
Apollo™ Onyx™ Delivery Micro Catheter 1.5 cm, Apollo™ Onyx™ Delivery Micro Catheter 3.0 cm
PMA Number
P030004
Supplement Number
S031
Device Class
FDA Class 3
Product Code
MFE
Generic Name
Agent, injectable, embolic
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 16, 2024
Date Received
March 19, 2024
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

approval for the additional supplier for the Hub used in the delivery catheter.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MFE Agent, Injectable, Embolic